Abbreviation
|
Formula
|
Mass
|
Main Class
|
Sub Class
|
GlcNAcβ1-3Galβ1-4Glcβ-Cer 34:1;O2
|
C54H100N2O18
|
1064.697119
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
GlcNAcβ1-3Galβ1-4Glcβ-Cer 36:1;O2
|
C56H104N2O18
|
1092.728419
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
GlcNAcβ1-3Galβ1-4Glcβ-Cer 38:1;O2
|
C58H108N2O18
|
1120.759719
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
GlcNAcβ1-3Galβ1-4Glcβ-Cer 40:1;O2
|
C60H112N2O18
|
1148.791019
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
GlcNAcβ1-3Galβ1-4Glcβ-Cer 42:2;O2
|
C62H114N2O18
|
1174.806669
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
GlcNAcβ1-3Galβ1-4Glcβ-Cer 42:1;O2
|
C62H116N2O18
|
1176.822320
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
GlcNAcβ1-3Galβ1-4Glcβ-Cer 44:2;O2
|
C64H118N2O18
|
1202.837970
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
GlcNAcβ1-3Galβ1-4Glcβ-Cer 44:1;O2
|
C64H120N2O18
|
1204.853620
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 34:1;O2
|
C60H110N2O23
|
1226.749944
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 36:1;O2
|
C62H114N2O23
|
1254.781245
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 38:1;O2
|
C64H118N2O23
|
1282.812545
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 40:1;O2
|
C66H122N2O23
|
1310.843845
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 42:2;O2
|
C68H124N2O23
|
1336.859495
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 42:1;O2
|
C68H126N2O23
|
1338.875145
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 44:2;O2
|
C70H128N2O23
|
1364.890795
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 44:1;O2
|
C70H130N2O23
|
1366.906445
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
Fucα1-2Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 34:1;O2
|
C66H120N2O27
|
1372.807855
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
Galβ1-3(Fucα1-4)GlcNAcβ1-3Galβ1-4Glcβ-Cer 34:1;O2
|
C66H120N2O27
|
1372.807855
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
Galα1-3Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 34:1;O2
|
C66H120N2O28
|
1388.802770
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
Galβ1-3Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 34:1;O2
|
C66H120N2O28
|
1388.802770
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
Fucα1-2Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 36:1;O2
|
C68H124N2O27
|
1400.839155
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
Galβ1-3(Fucα1-4)GlcNAcβ1-3Galβ1-4Glcβ-Cer 36:1;O2
|
C68H124N2O27
|
1400.839155
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
Galα1-3Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 36:1;O2
|
C68H124N2O28
|
1416.834070
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
Galβ1-3Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 36:1;O2
|
C68H124N2O28
|
1416.834070
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
Fucα1-2Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 38:1;O2
|
C70H128N2O27
|
1428.870455
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
Galβ1-3(Fucα1-4)GlcNAcβ1-3Galβ1-4Glcβ-Cer 38:1;O2
|
C70H128N2O27
|
1428.870455
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
GlcNAcβ1-3Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 34:1;O2
|
C68H123N3O28
|
1429.829318
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
Galα1-3Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 38:1;O2
|
C70H128N2O28
|
1444.865370
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
Galβ1-3Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 38:1;O2
|
C70H128N2O28
|
1444.865370
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
Fucα1-2Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 40:1;O2
|
C72H132N2O27
|
1456.901755
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
Galβ1-3(Fucα1-4)GlcNAcβ1-3Galβ1-4Glcβ-Cer 40:1;O2
|
C72H132N2O27
|
1456.901755
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
GlcNAcβ1-3Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 36:1;O2
|
C70H127N3O28
|
1457.860618
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
Galα1-3Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 40:1;O2
|
C72H132N2O28
|
1472.896670
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
Galβ1-3Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 40:1;O2
|
C72H132N2O28
|
1472.896670
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
Fucα1-2Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 42:2;O2
|
C74H134N2O27
|
1482.917405
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
Galβ1-3(Fucα1-4)GlcNAcβ1-3Galβ1-4Glcβ-Cer 42:2;O2
|
C74H134N2O27
|
1482.917405
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
Fucα1-2Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 42:1;O2
|
C74H136N2O27
|
1484.933055
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
Galβ1-3(Fucα1-4)GlcNAcβ1-3Galβ1-4Glcβ-Cer 42:1;O2
|
C74H136N2O27
|
1484.933055
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
GlcNAcβ1-3Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 38:1;O2
|
C72H131N3O28
|
1485.891919
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
Galα1-3Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 42:2;O2
|
C74H134N2O28
|
1498.912320
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
Galβ1-3Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 42:2;O2
|
C74H134N2O28
|
1498.912320
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
Galα1-3Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 42:1;O2
|
C74H136N2O28
|
1500.927970
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
Galβ1-3Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 42:1;O2
|
C74H136N2O28
|
1500.927970
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
Fucα1-2Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 44:2;O2
|
C76H138N2O27
|
1510.948705
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
Galβ1-3(Fucα1-4)GlcNAcβ1-3Galβ1-4Glcβ-Cer 44:2;O2
|
C76H138N2O27
|
1510.948705
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
Fucα1-2Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 44:1;O2
|
C76H140N2O27
|
1512.964355
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
Galβ1-3(Fucα1-4)GlcNAcβ1-3Galβ1-4Glcβ-Cer 44:1;O2
|
C76H140N2O27
|
1512.964355
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
GlcNAcβ1-3Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 40:1;O2
|
C74H135N3O28
|
1513.923219
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
Fucα1-2Galβ1-3(Fucα1-4)GlcNAcβ1-3Galβ1-4Glcβ-Cer 34:1;O2
|
C72H130N2O31
|
1518.865765
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|
Galα1-3Galβ1-3GlcNAcβ1-3Galβ1-4Glcβ-Cer 44:2;O2
|
C76H138N2O28
|
1526.943620
|
Neutral glycosphingolipids [SP05]
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) [SP0504]
|